GlassScriptPhysician profile
William P Berkery
NPI 1992770606
$1,901.31
in general payments reported to CMS, 2019-2025
26 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,078 · 2020: $153 · 2021: $97.49 · 2022: $12.66 · 2023: $66.09 · 2024: $312 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $234.80 | 2019-2024 | |
| Amgen INC. | $188.75 | 2019-2020 | |
| Abiomed | $180.78 | 2023-2025 | Impella |
| Medtronic, INC. | $175.68 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $141.89 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.55 | 2019-2020 | |
| Pfizer INC. | $127.37 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $110.54 | 2019 | |
| Merck Sharp & Dohme LLC | $96.89 | 2024 | Winrevair |
| Vifor Pharma, INC. | $80.00 | 2021 | |
| Amarin Pharma, INC. | $71.54 | 2019 | |
| Edwards Lifesciences Corporation | $58.36 | 2019-2020 | |
| Gilead Sciences, INC. | $49.73 | 2019 | |
| Boston Scientific Corporation | $35.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $35.44 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $30.63 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $22.55 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $18.82 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.29 | 2023 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $15.92 | 2019 | |
| Bridgebio Pharma, INC. | $15.05 | 2025 | Attruby |
| United Therapeutics Corporation | $15.01 | 2020 | |
| Lantheus Medical Imaging, INC. | $14.37 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.89 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.66 | 2022 | |
| Terumo Medical Corporation | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Berkery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.